Key result
Morphogenetic proteins such as FGF-23 and Klotho are promising alternative markers for assessing renal function and predicting adverse cardiovascular outcomes in patients with acute coronary syndrome.
Why the study?
Does the assessment of morphogenetic proteins (FGF-23, Klotho) predict adverse cardiovascular complications in patients with acute coronary syndrome?
Systematic Review
Does the assessment of morphogenetic proteins (FGF-23, Klotho) predict adverse cardiovascular complications in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Morphogenetic proteins such as FGF-23 and Klotho represent promising novel biomarkers for stratifying cardiovascular risk in patients with acute coronary syndrome and renal dysfunction, though further research is needed.
() - . (), 2015 17,5 , 31% , 50% .
No takes yet. Share an insight, caveat, or question.
Жунуспекова et al. (2019) conducted a systematic review in Acute coronary syndrome and renal dysfunction. Morphogenetic proteins (FGF-23, Klotho) was evaluated. Morphogenetic proteins such as FGF-23 and Klotho are promising alternative markers for assessing renal function and predicting adverse cardiovascular outcomes in patients with acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: